BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Valeant Pharmaceuticals, Allergan sales and marketing update

Allergen granted Valeant's Biovail Laboratories International SRL subsidiary exclusive Canadian rights to Aczone dapsone topical gel 5% to treat acne vulgaris. Allergan will receive C$500,000 ($506,050)...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >